By transfecting wild‐type or dead‐enzyme mutants of SIRT1 or SIRT2 into tumour cells, we found that the loss of SIRT2 deacetylase activity resulted in consistent levels of LIFR‐K620 acetylation (Figure 2I). Here, SIRT1 is linked to neoplasm.